Psychiatr. pro Praxi, 2002; 2: 50-53

Měření poruch sexuálních funkcí při léčbě psychofarmaky

MUDr. Alexandra Žourková CSc
Psychiatrická klinika LF MU a FN Brno

Keywords: sexual dysfunction, ASEX, psychotropic medication.

Published: December 31, 2002  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Žourková A. Měření poruch sexuálních funkcí při léčbě psychofarmaky. Psychiatr. praxi. 2002;3(2):50-53.

Autorka popisuje nejčastěji užívané dotazníky a škály ke sledování sexuálních funkcí ve světovém a domácím písemnictví (CSFQ, ASEX, UKU, IIEF, SFM, SFŽ). Pro jednoduchost hodnocení, malou časovou náročnost a schopnost zachytit závažnost sexuální dysfunkce doporučuje užití škály ASEX pro ty lékaře, kteří by chtěli monitorovat kvalitu sexuálního života svých pacientů. Český překlad škály je součástí sdělení.

MONITORING OF SEXUAL DYSFUNCTIONS TREATED BY PSYCHOPHARMACEUTICS

The author describes the most commonly used questionnaires and scales found in foreign and home literature (CSFQ, ASEX, UKU, IIEF, SFM, SFŽ) and used for the monitoring of sexual functioning The ease of evaluation, the brevity of application and the capacity for identifying the severity of sexual dysfunction are the reasons why she recommends the ASEX scales to those physicians willing to monitor the quality of their patients- sex life. The Czech translation of the scale is part of the paper.

Download citation

References

  1. Bancroft J. Human sexuality and its problems. Edinburgh: Churchill Livingstone (1989).
  2. Burešová A, Bártová D, Švestka J. Comparison of pharmacotherapeutic procedures in the treatment of sexual deviant behavior. Activ nerv sup 1990; 32: 299-301.
  3. Clayton AH, McGarvey EL, Clavet GJ. Changes in sexual functioning questionnare (CSFQ) - validization study. Psychophacolo Bull 1996; 32: 423.
  4. Demyttenaere K, DeFruyt J, Sienaert P. Psychotropics and sexuality. Int Clinical Psychopharmacology 1998; 13 (Suppl. 6): 35-41. Go to original source... Go to PubMed...
  5. Harvey KV, Balon R. Clinical implications of antidepressant drug effects on sexual function. Annals of clinical psychiatry 1995; 7: 189-201. Go to original source... Go to PubMed...
  6. Lingjaerde O, Ahlfors VG, Dencker SJ, Elgen K. The UKU side effects rating scale for psychotropic drugs and a cross sectional study of side effects in antipsychotic patients. Acta Psychiatr Scand Suppl 1987; 334-376. Go to original source... Go to PubMed...
  7. McGahuey CA, Delgado PL, Gelenberg AJ. Assessment of sexual dysfunction using the Arizona sexual experiences scale (ASEX) and implications for the treatment of depression. Psychiatric annals 1999; 29: 39-45. Go to original source...
  8. Mellan J. Vyšetřovací schéma sexuálních poruch u mužů. Čs Psychiat 1964; 60: 326-333.
  9. Mellan J. K otázce sexuální vzrušivosti žen II. Čs. gynekologie 1978; 43: 432-434.
  10. Pfeiffer W, Kockott G, Fischl B, Schleuning G. Unerwunschte Wirkungen psychopharmakologischer Langzeitherapie auf die sexuellen Funktionen. Psychiatr Prax 1991; 18: 92-98. Go to PubMed...
  11. Piazza LA, Markowitz JC, Kocsis JH, Leon AC, Portera L, Miller NL, Adler D. Sexual functioning in chronically depressed patients treated with SSRI antidepressants. A pilot study, Am J Psychiatry 1997; 154: 1757-1759. Go to original source... Go to PubMed...
  12. Raboch J jr, Hořejší J, Raboch J. Pseudohermaphroditismus masculinus - sexuální vývoj a pohlavní život. Čes a Slov Psychiat 2000; 96: 192-194.
  13. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830. Go to original source... Go to PubMed...
  14. Zbytovský J, Zapletálek M. Haloperidol decanoate in the treatment of sexual deviations. Activ nerv sup 1989; 31: 41-42.
  15. Žourková A, Hadašová E, Robeš M. Sexual functions in treatment with paroxetine. Homeostasis 2000; 40: 249-251.




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.